| NCT ID | NCT06584929 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Masonic Cancer Center, University of Minnesota |
| Condition | Smoking Cessation |
| Study Type | INTERVENTIONAL |
| Enrollment | 272 participants |
| Start Date | 2026-03-17 |
| Primary Completion | 2028-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 272 participants in total. It began in 2026-03-17 with a primary completion date of 2028-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Understanding ways to help people who live in rural areas quit smoking is a public health priority. quitting smoking among rural people who smoke is a critical public health concern. People in rural areas smoke at higher rates than those in urban areas, experience high rates of smoking caused cancers and deaths. We are recruiting rural people from around the country to better understand how different quit smoking methods can improve a person's chances of successfully quitting smoking.
Eligibility Criteria
Inclusion Criteria: * ≥ 21 years * smoke ≥ 5 cigarettes per day * daily access to their own iPhone/Android smartphone or tablet Exclusion Criteria: * past 30-day NRT use or contraindications listed on the NRT labels * currently pregnant/breastfeeding
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06584929 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Smoking Cessation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06584929 currently recruiting?
Yes, NCT06584929 is actively recruiting participants. Contact the research team at dcarroll@umn.edu for enrollment information.
Where is the NCT06584929 trial being conducted?
This trial is being conducted at Minneapolis, United States.
Who is sponsoring the NCT06584929 clinical trial?
NCT06584929 is sponsored by Masonic Cancer Center, University of Minnesota. The trial plans to enroll 272 participants.